Clinical Trial Update: Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing endoscopic fundoplication to proton pump inhibitors for gastroesophageal reflux disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: University of Pittsburgh | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 3 | Status: TERMINATED